A phase III trial of larazotide for celiac disease

Trial Profile

A phase III trial of larazotide for celiac disease

Planning
Phase of Trial: Phase III

Latest Information Update: 06 Sep 2017

At a glance

  • Drugs Larazotide (Primary)
  • Indications Coeliac disease
  • Focus Registrational; Therapeutic Use
  • Sponsors Innovate Biopharmaceuticals
  • Most Recent Events

    • 06 Sep 2017 According to an Innovate Biopharmaceuticals media release, this trial is expected to start in late 2017.
    • 28 Nov 2016 This trial is expected to start in 2017, according to an Innovate Pharma media release.
    • 03 Mar 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top